How the COVID-19 monitor improves treatments and supports LCG to signal possible drug shortages
About the collaboration
The National Medication Coordination center (Landelijk Coördinatiecentrum Geneesmiddelen) asked us to create a monitor that keeps track of drug use and patterns in hospitalised COVID-19 patients to support them to signal possible shortages and respond proactively.
As COVID is a relatively new disease, treatments change quickly, as does the number of patients, leading to shortages of beneficial drugs. The monitor aims to prevent these drug shortages by analysing and extrapolating drug use—both known treatments, but especially in emerging new uses.
One of the main treatments for COVID-19 patients is tocilizumab. It is great news for patients, but it is now also flagged for a potential shortage with the new wave of COVID admissions. Therefore, the LCG needed to know the exact numbers and patterns of tocilizumab use to communicate with suppliers, the Ministry of Health, and potentially parliament to determine their actions to prevent the shortage.
The provided information was precise and therefore useful. We expected 50% of COVID-19 patients treated with this medication, but it appeared to be >60%. These insights supported us in making better decisions and tackling the potential shortages.LCG (Landelijk Coordinatiecentrum Geneesmiddelen)
Our Life Science Team launched the COVID-19 monitor that keeps track of drug use and patterns in hospitalised COVID-19 patients and supports signalling possible drug shortages.
We are now supporting the LCG (National Coordination Center for Prescription Drugs) on a monthly basis by analysing the hospital data to provide insights into the drug use of COVID-19 patients.
As a result, we have expanded both the data depth with prescription data (EVS) and the number of hospitals to 45. For that reason, we can provide insights into add-on medication and other medication used by COVID-19 patients. This project shows our continued effort to be an impact leader in our field.
LOGEX Value Analytics combine near real-time information from the front line, adjusted for case mix performance, with insights from our benchmarking platform to drive improvement in both outcomes and costs.
Our Value Analytics solutions highlight:
Opportunities for improvement
See exactly where your team is doing well, and where efforts should be targeted
Progress in improvement projects
Track shared goals as a team, showing deviation from defined targets
Potential adverse events before they happen
Get early alerts of adverse events and changes in clinical practice
Impact on outcomes and costs
See how patient characteristics and care processes interact to affect outcomes and costs
Risk groups that need timely action
Spot patients at risk of poor outcomes or high cost, so you can take proactive measures